Skip to main content
Loading

Imagion Biosystems

October 17, 2023
Franciscan D
Diagnostics
Company Description: Imagion Biosystems, Ltd. (ASX: IBX) is pioneering molecularly targeted MRI Contrast Agents with its MagSense® technology - a new functional imaging product line that holds the promise of being more sensitive and safer for detecting cancers and other critical diseases. Specialized bio-safe magnetic nanoparticles are coated with tumor-targeting molecules that are able to circulate through normal blood flow or local injection. When bound to a tumor the MagSense particles can then be detected by Magnetic Resonance Imaging scanners.
Speakers
Isaac Bright, CEO - Imagion Biosystems